THREE RIVERS PHARMACEUTICALS

Three Rivers Pharmaceuticals, LLC develops, manufactures, and markets generic pharmaceutical drug products in the United States and internationally. It offers prescription drugs in the therapeutic categories of antiviral and antifungal agents. The company’s products include AMPHOTEC for the treatment of invasive aspergillosis, a systemic fungal infection; and INFERGEN, RIBASPHERE tablets, RIBASPHERE capsules, and RibaPak tablets for the treatment of hepatitis C. It also markets Topotecan Hydrochloride for injection. Three Rivers Pharmaceuticals, LLC was founded in 2000 and is based in Warrendale, Pennsylvania. As of October 25, 2010, Three Rivers Pharmaceuticals, LLC operates as a subsidiary of Kadmon Pharmaceuticals LLC.